ATG5 as a Serum Marker of Autophagy in Psoriatic Patient

Sohag University

Status: Unknown

Conditions: Autophagy; Psoriasis Vulgaris

Treatments: Diagnostic Test: serum ATG5

Study type: Observational

Funder types: Other

Identifiers

NCT05279638

Soh-Med-22-02-03

Details and patient eligibility

About

it will be of interest to know the ATG 5 as a serum marker of autophagy in serum of psoriasis vulgairs patients and explore its relationship with psoriasis severity.

Enrollment: 90 estimated patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Psoriasis vulgaris of both sex, age 18-55 years

Exclusion criteria

i. Patients with other types of psoriasis ii. Pregnant or lactating women iii. patients with hepatic or renal diseases iv. patients receive any systemic treatment in last 3 months

Trial design

90 participants in 2 patient groups

psoriasis vulgaris patients

Description:

psoriasis vulgaris patients , both sex , 18,55 years old

Treatment:

Diagnostic Test: serum ATG5

healthy participants

Treatment:

Diagnostic Test: serum ATG5